Business
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment – Sydney Morning Herald
The pharma giant has started the approvals process for a drug similar to what Donald Trump received.
GSK announced last year it plans to close its Melbourne manufacturing site in Boronia at the end of 2022 after 50 years. The companys research on the COVID treatment has all taken place overseas, with Australias low case numbers meaning it is difficult to run trials for treatments here.
Australia is currently focused on the rollout of coronavirus vaccines, but the local biotech sector has long said there needs to be more treatment options for patients who present with the virus – particularly as…
-
Business23 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News18 hours agoTwo trapped and fighting for life after major three-vehicle crash in Brisbane
-
Business19 hours agoUp 105% in a year, are Pro Medicus shares still a good buy today?
-
Business17 hours agoEverything you need to know about the Coles dividend